Search

everythinglearnresearchcommunity

for

Search:↓

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Analog 23 is a promising compound for prostate cancer treatment.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Male pattern baldness does not cause an increased risk of prostate cancer.

Mutations in certain receptors can cause diseases and offer new treatment options.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Adding a second method to PROTACs could improve cancer treatment.

Bicalutamide may help treat female pattern hair loss.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.